Cervical Preparation for Dilation and Curettage
For routine first-trimester D&C, cervical preparation with misoprostol (400 μg vaginal or sublingual) administered 2-3 hours prior to the procedure is recommended, as it significantly reduces intra-procedural pain and facilitates cervical dilation, though it is safe to proceed without preparation in many cases. 1
Evidence-Based Approach by Clinical Context
First Trimester D&C (≤12-14 weeks)
Pharmacologic preparation:
- Misoprostol 400 μg is the preferred agent when cervical preparation is used 2
- Vaginal route: 3 hours prior to procedure (more effective than 2 hours)
- Sublingual route: 2-3 hours prior (superior cervical effects compared to vaginal, with lower side-effect rates)
- Oral route is less effective and associated with more gastrointestinal side effects
When preparation is most beneficial:
- Nulliparous women
- Cervical stenosis (prior cervical surgery, postmenopausal status)
- Gestational age >12 weeks
- Note: Misoprostol is less effective in nulliparous and postmenopausal women 3
Alternative agents:
- Mifepristone 200 mg (24 hours prior): Superior cervical effects to misoprostol but requires day-prior administration 2
- Osmotic dilators (laminaria tents): More effective than misoprostol but associated with more insertion pain and require overnight placement 4
Second Trimester D&C/D&E (14-24 weeks)
Osmotic dilators are superior to prostaglandins alone for second-trimester procedures 5, 6
Optimal protocol:
- Osmotic dilators (laminaria or Dilapan-S) PLUS misoprostol 400 μg buccal on day of procedure 6
- This combination probably increases dilation achieved (MD 1.83 mm) and reduces need for additional dilation (RR 0.65) compared to osmotic dilators alone
- Overnight placement (12-24 hours) is standard for ≥14 weeks
Timing considerations:
- One-day preparation is adequate for <19 weeks gestation
- Two-day preparation may be needed for ≥19 weeks or challenging cases 5
Special Circumstance: Molar Pregnancy
Cervical preparation is SAFE in molar pregnancy 7
- Either physical dilators or prostaglandins can be used
- No increased risk of gestational trophoblastic neoplasia (GTN) with cervical ripening
- AVOID oxytocic agents (oxytocin, ergometrine, misoprostol as uterotonic) until evacuation is complete due to risk of trophoblastic tissue embolization and respiratory distress
Pain Management Considerations
The 2024 RCOG guideline demonstrates that oral NSAIDs significantly reduce both intra-procedural and post-procedural pain (SMD -0.87 during and -0.56 after procedure) 1. Administer NSAIDs prophylactically before the procedure.
Common Pitfalls to Avoid
- Timing errors: Vaginal misoprostol given <3 hours prior is less effective; sublingual can be given 2-3 hours prior
- Route confusion: Oral misoprostol has inferior efficacy and more side effects than vaginal or sublingual routes
- Gestational age misjudgment: Preparation becomes increasingly important after 12 weeks when mechanical dilation becomes more difficult
- Molar pregnancy management: Never use oxytocics until evacuation is complete to prevent tissue embolization
- Postmenopausal/nulliparous patients: Expect reduced efficacy of misoprostol; consider osmotic dilators or mifepristone
Side Effects Profile
- Misoprostol: Vaginal bleeding (may cause complete abortion in 2-7% of cases), cramping, gastrointestinal symptoms
- Osmotic dilators: Insertion pain, requires return visit, rare expulsion
- Mifepristone: Prolonged time interval, higher cost
When Preparation May Be Omitted
For experienced operators performing first-trimester D&C in multiparous women with favorable cervical anatomy at <10 weeks gestation, proceeding without preparation is reasonable, as the benefits may not outweigh the side effects and time delay 2.